CiBB - Centre for Innovative Biomedicine and Biotechnology, is a Research Center of excellence in the domains of Biomedicine and Biotechnology, which results from a consortium joining CNC-UC - Center for Neuroscience and Cell Biology and iCBR-FMUC - Coimbra Institute for Clinical and Biomedical Research. In 2024, the Teaming projects MIA-Portugal: Multidisciplinary Institute of Ageing and GeneT - Gene Therapy Center of Excellence have integrated the CiBB multidisciplinary structure.
With the largest critical mass of researchers in the Centre Region of Portugal, internationally recognized and linked to the Faculties of Pharmacy, Medicine, Sciences and Technology and Economics, as well as to the Institute of Interdisciplinary Research and to the Coimbra University Hospital, CiBB has a high-level of scientific production and attracts talent and funding at national and international levels.
The CiBB stands as the flagship of Biomedical and Biotechnology Sciences at the University of Coimbra (UC). It is the largest R&D Unit in the center region of Portugal and the sole UC-coordinated Associate Laboratory (top 100% evaluation), welcoming circa 700 members.
CiBB comprises 37 dynamic and multidisciplinary research groups, dedicated to understanding how and why diseases develop, particularly those associated with aging, and translating this understanding into clinical applications and technological breakthroughs.
More about CiBB here.
